Kenji Hirayama

Organization・Title
Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN) , Nagasaki University, Nagasaki, Japan, Professor
Special field
Parasitology, Molecular Immunogenetics
Research themes
Genetic susceptibility to Tropical Infectious Diseases, Malaria/NTD vaccine development

Boys and Girls, Be Ambitious.

Course List

Research Ethics

Recommended books

Harrison Internal Medicine

Homepage

http://www.tm.nagasaki-u.ac.jp/nekken/english/research/immunogenetics.html

personal history

1986-1988 Assistant Professor at Kyushu University 
1988-1993 Lecturer at St.Marianna Medical University
1988-1991 Research Fellow at Harvard School of Public Health
1993-1995 Associate Professor at Saitama Medical School
1955-2001 Professor at Saitama Medical School
2001-Present Professor at Nagasaki University
2001-Present Steering Committee member of Forum for Ethical Review
Committee members in Asia and Pacific Regions
2004 ? 2006 Vice-President, Nagasaki University
2004 ? 2007 Deputy Dean, Institute of Tropical Medicine, Nagasaki University
April, 2007 ? March, 2011 Dean, Institute of Tropical Medicine, Nagasaki Universityt
2007-Present Chair of Japanese Panel of Parasitic Diseases, United States Japan Cooperative Medical Program
Feb 1, 2008- Feb 16, 2010 Chairperson, Research Training Steering Committee (TSC) Business Line 2 (BL2) Empowerment TDR/WHO, Geneva, Switzerland
2009-Present Chairperson The Forum for Ethical Review Committees in Asia an Western Pacific Region (FERCAP)

works/thesis

1. Del Puerto F, Nishizawa JE, Kikuchi M, Roca Y, Avilas C, Gianella A, Lora J, Velarde FU, Miura S, Komiya N, Maemura K, Hirayama K. Protective Human Leucocyte Antigen Haplotype, HLA-DRB1*01-B*14, against Chronic Chagas Disease in Bolivia. PLoS Negl Trop Dis. 2012 Mar;6(3):e1587. Epub 2012 Mar 20.

2. Cherif MS, Shuaibu MN, Kurosaki T, Helegbe GK, Kikuchi M, Yanagi T, Tsuboi T, Sasaki H, Hirayama K. Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration. Vaccine. 2011 Nov 8;29(48):9038-50. Epub 2011 Sep 20.

3. Nguyen TPL, Kikuchi M, Huong VTQ, Ngu VTT, Dao HN, Ha DQ, Thuy TT, Tham VD, Tuong VV, Nga CTP, Dat TV, Oyama T, Morita K, Yasunami M, Hirayama K. Protective and Enhancing HLA-alleles, HLA-DRB1*0901 and HLA-A*24, for Severe Forms of Dengue Virus Infection, Dengue Hemorrhagic Fever and Dengue Shock Syndrome. PLoS Neglected Tropical Diseases 2008 2(10): e304.

4. Hirayama K, Chen H, Kikuchi M, Yin D, Itoh M, Gu X, Zhang S, and Yuan H. Glycine-Valine dimorphism at the 86th amino acid of HLA-DRB1 influenced the prognosis of post-schistosomal hepatic fibrosis. J. Inf. Dis., 177,1682-1686,1998.

5. Hirayama K, Matsushita, S, Kikuchi, I, Iuchi, M, Ohta, N, & Sasazuki, T. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 327:426-430, 1987